Shruti Rastogi

Ghaziabad, UP 201002, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Indian Pharmacopoeia Reference Standards: A Key Tool to Regulate the Quality of Pharmaceuticals.

Indian Pharmacopoeia Reference Standards: A Key Tool to Regulate the Quality of Pharmaceuticals.

Journal: Therapeutic innovation & regulatory science
Published: September 01, 2025

Minimizing the risk of ethylene glycol and diethylene glycol poisoning in medications: A regulatory and pharmacopoeial response.

Minimizing the risk of ethylene glycol and diethylene glycol poisoning in medications: A regulatory and pharmacopoeial response.

Journal: Regulatory toxicology and pharmacology : RTP
Published: August 14, 2024

Retrospective analysis of neoplasms in patients using angiotensin receptor blockers.

Retrospective analysis of neoplasms in patients using angiotensin receptor blockers.

Journal: Scientific reports
Published: November 17, 2023

A comprehensive quality control and cost comparison study of branded and generic angiotensin receptor blockers.

A comprehensive quality control and cost comparison study of branded and generic angiotensin receptor blockers.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: October 10, 2023

Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia.

Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: August 10, 2023

Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis.

Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology
Published: January 31, 2023

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database.

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database.

Journal: Biology
Published: January 13, 2022

Pharmacopoeia roles and responses: A systemic resilience approach to COVID-19 pandemic.

Pharmacopoeia roles and responses: A systemic resilience approach to COVID-19 pandemic.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: December 23, 2021

Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis.

Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis.

Journal: Biology
Published: September 08, 2021

Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase®.

Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase®.

Journal: Seizure
Published: December 30, 2020

Towards a comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars in treating chemotherapy associated febrile neutropenia: Trends from decades of data.

Towards a comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars in treating chemotherapy associated febrile neutropenia: Trends from decades of data.

Journal: Toxicology and applied pharmacology
Published: October 31, 2019

Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects.

Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects.

Journal: Drug discovery today
Published: June 08, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026